NL-OMON32289
Completed
Phase 3
A randomized clinical trial of surgery or radiosurgery (stereotactic radiotherapy) in patients with stage IA non-small cell lung cancer who are fit to undergo primary resection - Randomized trial of surgery or radiosurgery in stage IA lung cancer
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- stage IA NSCLC
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 960
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age \* 18 years;Patients with a diagnosis of stage IA non\-cell lung cancer diagnosed in accordance with Dutch CBO guidelines. When no pathological diagnosis is available, a patient with a new or growing pulmonary lesion with radiological features consistent with malignancy AND a lesion showing uptake on a FDG\-PET scan will be eligible. ;No evidence of regional or distant metastases on a standardized FDG\-PET scan within 6 weeks of any protocol treatment .;Medial extension of tumours should be least 2 cm away from main and lobar bronchi, and also minimum of 1\.5 cm from large peripheral blood vessels such as the aorta and main pulmonary artery. Lesions of at least 2 cm from the mediastinal pleura will be eligible if the responsible radiation oncologist judges that the specified normal tissue tolerance doses specified in the protocol will not be exceeded.;Patients should be fit to undergo both surgery and SRT. ;Patients who are judged by a multi\-disciplinary team to have 2 primary lung tumors (on the basis of clinical, radiological, FDG\-PET and/or cyto\-pathology findings) are eligible for randomization provided that both surgery and SRT can be performed in accordance with protocol requirements.;Patient should be fit to undergo a complete surgical resection of the lesion in accordance with Dutch CBO guidelines \[2004] ;Performance score of ECOG \* 2 before any treatment.;Able to comply with post\-treatment follow\-up
Exclusion Criteria
- •Prior chemotherapy or radiotherapy for the present diagnosis of NSCLC. ;History of any active malignancy (other than NSCLC) unless treated more than 3 years with curative intent and no recurrence, with the exception of non\-melanoma skin cancers or in\-situ cervical cancers.;Any unstable systemic disease (including active infection, uncontrolled hypertension, unstable angina, congestive heart failure, myocardial infarction within the previous year, severe cardiac arrhythmia requiring medication, hepatic, renal or metabolic disease).;Concomitant treatment with any other experimental drug under investigation.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Randomised controlled trial of surgical treatment of varicose veins in legs: Stripping versus Conservative Treatment (CHIVA)ISRCTN52861672Spanish Ministry of Health, Investigation of Sanitary Funding (Fondo de Investigación Sanitaria Ministerio de Sanidad y Consumo)501
Recruiting
N/A
Prospective randomized clinical trial: Surgical success rates in childhood glaucoma: Conventional probe trabeculotomy versus microcatheter-assisted 360°trabeculotomyH40GlaucomaDRKS00034139niversitätsmedizin Mainz, Augenklinik76
Active, Not Recruiting
N/A
A trial of surgery versus no surgery in patients with severe pectus excavatum: looking at improvements in heart and lung functioCardiothoracic surgery, pectus excavatumSurgeryISRCTN11359779South Tees Hospitals NHS Foundation Trust300
Completed
Phase 2
Reconstruction of major extensive facial burn injuriesFacial Burn.Burns and corrosionsT20, T21,IRCT201307319044N2Vice chancellor for research, Iran University of Medical Sciences60
Completed
N/A
A randomised controlled trial, comparing Surgical Decompression with an Interspinous Implant in patients with Intermittent Neurogenic Claudication caused by Lumbar Stenosis.Spinal stenosis & pressure on the nerves causing leg pain1000595910043413NL-OMON31834Paradigm Spine / InSpine386